Company news

Co-Diagnostics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast

February 28, 2024

Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12

January 2, 2024

Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro

December 26, 2023

Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

November 8, 2023

Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development

November 1, 2023

Co-Diagnostics, Inc. Announces Third Quarter 2023 Earnings Release Date and Webcast

October 25, 2023

Co-Diagnostics, Inc. to Host Booth at CASMET Symposium October 23-25

October 22, 2023

Co-Diagnostics, Inc. to Participate in the 2023 UHCA/UCAL Fall Convention & Expo on Sept 27-28

September 26, 2023

Co-Diagnostics, Inc. Appoints Chief Regulatory Affairs Officer

August 28, 2023

Co-Diagnostics, Inc. Reports Second Quarter 2023 Financial Results

August 9, 2023

Co-Diagnostics, Inc. Announces Second Quarter 2023 Earnings Release Date and Webcast

July 26, 2023

Co-Diagnostics, Inc. to Host Booth and Discuss Recent Grant Awards at AACC 2023 in Anaheim, CA

July 19, 2023

Co-Diagnostics, Inc. Announces Recent Grant Awards

July 17, 2023

Co-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home Platform from NIH RADx® Tech Program

July 12, 2023

Co-Diagnostics, Inc. Reports First Quarter 2023 Financial Results

May 10, 2023

Co-Diagnostics, Inc. Announces First Quarter 2023 Earnings Release Date and Webcast

May 4, 2023

Co-Diagnostics, Inc. to Host Booth at 10th Gene Quantification Event in Munich, Germany, March 20-22

March 16, 2023

Co-Diagnostics, Inc. Reports Full Year 2022 Financial Results

March 15, 2023

Co-Diagnostics, Inc. announces fourth quarter and full year 2022 earnings release date and webcast

March 8, 2023

Co-Diagnostics, Inc. to Present and Host Booth at TRI-CON in San Diego, CA, March 6-8

March 1, 2023

Co-Diagnostics, Inc. Initiates Clinical Evaluations for its At-Home and Point-of-Care Co-Dx PCR Home™ Platform

February 21, 2023

Co-Diagnostics, Inc. to Host Booth at Medlab Middle East 2023 in Dubai on February 6-9

February 1, 2023

Co-Diagnostics, Inc. Commemorates Third Anniversary of the Completion of its First COVID-19 Test Design

January 23, 2023

Co-Diagnostics, Inc. to Host Booth at CES 2023 January 5-8

January 4, 2023

Co-Diagnostics, Inc. to Host Booth at MEDICA 2022 Trade Fair in Düsseldorf, Germany

November 13, 2022

Co-Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

November 9, 2022

Co-Diagnostics, Inc. Appoints Dr. Mark Poritz as New Chief Scientific Officer

October 31, 2022

Co-Diagnostics, Inc. announces third quarter 2022 earnings release date and webcast

October 26, 2022

Co-Diagnostics, Inc. to Host Booth at Medlab Africa on Oct 26-28 in South Africa

October 25, 2022

Co-Diagnostics, Inc. to Sponsor, Present, and Host Booth at 66th Annual CARPHA Conference on Sept 15-17 in Jamaica

September 13, 2022

Co-Diagnostics, Inc. to Host Booth at Medical Fair Asia 2022 in Singapore on Aug 31-Sep 2

August 30, 2022

Co-Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

August 10, 2022

Co-Diagnostics, Inc. Announces Shipment of Monkeypox Virus Test

July 10, 2022

Co-Diagnostics, Inc. to Host Booth at MEDEXPO Africa 2022 in Nairobi, Kenya on June 9-11

June 8, 2022

Co-Diagnostics, Inc. Completes Principal Design of Test for Monkeypox Virus

May 25, 2022

Co-Diagnostics Reports Solid First Quarter 2022 Financial Results

May 11, 2022

Co-Diagnostics, Inc. to Host Booth at Medical Fair Brasil 2022 in São Paulo on May 3-6

May 2, 2022

Co-Diagnostics, Inc. announces first quarter 2022 earnings release date and webcast

April 27, 2022

Co-Diagnostics, Inc. to Host Booth at ECCMID 2022 in Lisbon, Portugal on April 23-26

April 21, 2022

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis C Viral Load Test

April 18, 2022

Co-Diagnostics Reports Full Year 2021 Financial Results

March 23, 2022

Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board

March 16, 2022

Co-Diagnostics, Inc. Announces Authorization of $30 Million Share Repurchase Program

March 14, 2022

Co-Diagnostics, Inc. announces fourth quarter and full year 2021 earnings release date and webcast

March 13, 2022

Co-Diagnostics, Inc. to Sponsor and Present at Molecular Med Tri-Con 2022

February 16, 2022

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis B Viral Load Test

February 2, 2022

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex Test

January 12, 2022

Co-Diagnostics, Inc. Announces Completion of the Acquisition of all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform

December 30, 2021

Co-Diagnostics, Inc. Signs Agreement to Acquire all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform

December 21, 2021

Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for ABC Multiplex Test

December 6, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks